Supernus Pharmaceuticals INC
Experience in developing and commercializing products that treat central nervous system
Based in MD
🤖
AI Overview
With $320K in lobbying spend across 17 quarterly filings, Supernus Pharmaceuticals INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2022 to 2025.
$320K
Total Spend
4
Years Active
1
Firms Hired
10
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $60K |
| 2023 | $80K |
| 2024 | $100K |
| 2025 | $80K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues
- •Issues related to Medicare Part B and Part D and issues related to the pharmaceutical industry
- •issues related to the pharmaceutical industry
- •issues related to Medicare drug reimbursement
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
Plasma Protein Therapeutics Association
$4.8M total spend
Digestive Health Physicians Association, INC.
$2.0M total spend
American Society of Addiction Medicine
$1.9M total spend
Association for Molecular Pathology
$1.5M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.